In a very new study, we claimed the identification as well as the characterization of a different atypical opioid receptor with special negative regulatory Houses toward opioid peptides.1 Our benefits showed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is usually a https://margareth503kxq1.bloggactif.com/profile